Syros Pharmaceuticals, Inc. (SYRS)
NASDAQ: SYRS · Real-Time Price · USD
0.260
-0.030 (-10.34%)
Nov 21, 2024, 4:00 PM EST - Market closed
Syros Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 7 | 203 | 73 | 202 | 609 | 293 | |
| Market Cap Growth | -29.54% | 179.01% | -64.04% | -66.84% | 107.64% | 56.45% | |
| Enterprise Value | 10 | 153 | -108 | 101 | 563 | 206 | |
| Last Close Price | 0.29 | 7.79 | 3.59 | 32.60 | 108.50 | 69.10 | |
| PS Ratio | 27.64 | 20.39 | 4.88 | 8.60 | 40.35 | 147.97 | |
| PB Ratio | -5.18 | 12.16 | 0.57 | 2.37 | 6.72 | 3.70 | |
| P/TBV Ratio | - | 12.16 | 0.57 | 2.37 | 6.72 | 3.70 | |
| EV/Sales Ratio | 25.20 | 15.38 | - | 4.29 | 37.27 | 104.14 | |
| Debt / Equity Ratio | -5.41 | 3.73 | 0.50 | 0.76 | 0.73 | 0.33 | |
| Asset Turnover | 0.00 | 0.05 | 0.07 | 0.12 | 0.08 | 0.02 | |
| Quick Ratio | 2.05 | 3.80 | 6.63 | 4.23 | 6.16 | 4.74 | |
| Current Ratio | 2.25 | 3.95 | 6.87 | 4.33 | 6.24 | 4.87 | |
| Return on Equity (ROE) | -776.96% | -227.94% | -88.90% | -98.49% | -99.02% | -95.63% | |
| Return on Assets (ROA) | -59.88% | -38.32% | -36.95% | -31.37% | -28.32% | -37.85% | |
| Return on Capital (ROIC) | -94.28% | -58.55% | -46.22% | -40.46% | -39.28% | -52.89% | |
| Earnings Yield | -1258.10% | -81.23% | -130.36% | -42.86% | -13.80% | -25.72% | |
| FCF Yield | -1286.90% | -54.29% | -171.19% | -49.91% | -9.97% | -24.85% | |
| Buyback Yield / Dilution | -31.77% | -124.24% | -102.00% | -35.79% | -14.49% | -23.17% | |
| Total Shareholder Return | -31.77% | -124.24% | -102.00% | -35.79% | -14.49% | -23.17% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.